Patients' perspective on the medical pathway from first symptoms to diagnosis in genetic lipodystrophy.

MLA

Mosbah, Héléna, et al. “Patients’ Perspective on the Medical Pathway from First Symptoms to Diagnosis in Genetic Lipodystrophy.” European Journal of Endocrinology, vol. 190, no. 1, Jan. 2024, pp. 23–33. EBSCOhost, https://doi.org/10.1093/ejendo/lvad169.

APA

Mosbah, H., Vatier, C., Andriss, B., Belalem, I., Delemer, B., Janmaat, S., Jéru, I., Collen, L. L., Maiter, D., Nobécourt, E., Vantyghem, M.-C., PRISIS), Network « Pathologies Rares de l’Insulino-Sécrétion et de l’Insulino-Sensibilité », Vigouroux, C., & Dumas, A. (2024). Patients’ perspective on the medical pathway from first symptoms to diagnosis in genetic lipodystrophy. European Journal of Endocrinology, 190(1), 23–33. https://doi.org/10.1093/ejendo/lvad169

Chicago

Mosbah, Héléna, Camille Vatier, Béatrice Andriss, Inès Belalem, Brigitte Delemer, Sonja Janmaat, Isabelle Jéru, et al. 2024. “Patients’ Perspective on the Medical Pathway from First Symptoms to Diagnosis in Genetic Lipodystrophy.” European Journal of Endocrinology 190 (1): 23–33. doi:10.1093/ejendo/lvad169.